Drug Type Cell therapy |
Synonyms AntiCOVID19 DARNKcell therapy Sorrento Therapeutics, AntiCOVID2019 DARNKcell therapy Sorrento Therapeutics |
Target |
Action inhibitors |
Mechanism SARS-CoV-2 antigen inhibitors, Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | United States | - |